Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > SP deep discount

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Oct 20, 2021 2:44pm

102 Views

Post# 34028308

SP deep discount

Previous financing few months back was sold at 40 cents per share and it was oversubscribed. From that time we are weeks away from Reduvo approval, finishing reborn trial enrolment and interim report for both reborn and plenitude and current sp is at 23 cents. That summarizes it. Gl longs. Btw investors were not happy about the 40 cents as it was too low.

<< Previous

Bullboard Posts

Next >>

Volatus Aerospace expands oil and gas surveillance into the U.S.